Dermatology
Plastic Surgery
General Practice
High Evidence
Peer reviewed

Skin Biopsy Techniques

Skin biopsy is a fundamental diagnostic procedure in dermatology, primary care, and plastic surgery, used to obtain tiss... MRCS exam preparation.

Updated 9 Jan 2026
Reviewed 17 Jan 2026
34 min read
Reviewer
MedVellum Editorial Team
Affiliation
MedVellum Medical Education Platform

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Shave Biopsy on suspected Melanoma (Destroys Breslow depth staging)
  • Biopsy of Vascular Lesion without haemostatic preparation
  • Uncontrolled Anticoagulation (INR less than 3.5)
  • Active Infection at biopsy site

Exam focus

Current exam surfaces linked to this topic.

  • MRCS

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Melanoma Staging
  • Inflammatory Dermatoses

Editorial and exam context

Reviewed by MedVellum Editorial Team · MedVellum Medical Education Platform

Credentials: MBBS, MRCP, Board Certified

MRCS
Clinical reference article

Skin Biopsy Techniques

1. Procedure Overview

Summary

Skin biopsy is a fundamental diagnostic procedure in dermatology, primary care, and plastic surgery, used to obtain tissue for histopathological and immunological analysis. [1,2] The four principal techniques are punch biopsy, shave biopsy, incisional biopsy, and excisional biopsy. Selection of the appropriate technique depends upon the suspected pathology, lesion depth, anatomical location, and cosmetic considerations. [3]

Correct technique selection is paramount: a shave biopsy on a suspected melanoma constitutes a serious clinical error as it prevents accurate Breslow depth measurement, which is essential for staging and determining surgical margins. [4,5] This comprehensive guide covers indications, technique selection, procedural steps, specimen handling, post-procedure care, and common pitfalls relevant to postgraduate examinations.

Key Facts

TechniqueTissue DepthPrimary IndicationClosureScarring
Shave BiopsyEpidermis ± superficial dermisRaised benign lesions (SK, skin tags)Secondary intentionFlat, hypopigmented
Punch BiopsyFull-thickness (epidermis to subcutis)Inflammatory dermatoses, bullous disease1-2 sutures or secondary intentionSmall circular/elliptical
Incisional BiopsyPartial lesion with deep tissueLarge tumours, panniculitisSuturesLinear
Excisional BiopsyEntire lesion with marginSuspected melanoma, complete removalLayered closureElliptical

Critical Safety Points

The Melanoma Rule: If there is ANY doubt about a pigmented lesion, excise completely with 2mm clinical margin. A shave biopsy that transects a melanoma destroys Breslow depth information essential for staging and prognosis. [4,5,6]

The SCC Rule: For suspected squamous cell carcinoma on sun-damaged skin, a deep shave (saucerization) or punch biopsy is acceptable for diagnosis, but definitive excision with appropriate margins must follow if malignancy is confirmed. [7]

The Adrenaline Myth: The historical teaching to avoid adrenaline-containing local anaesthetics in fingers, toes, ears, nose, and penis has been definitively disproven. Multiple large studies demonstrate safety with no cases of digital necrosis. [8,9,10]

The DIF Rule: For suspected autoimmune bullous disease, Direct Immunofluorescence requires perilesional skin in Michel's transport medium, NOT formalin. Formalin destroys immunoglobulins. [11,12]

Why This Matters Clinically

Skin biopsy is one of the most commonly performed procedures in medicine, with over 10 million performed annually in the United States alone. [13] A poorly chosen technique can delay diagnosis, cause cosmetic disfigurement, or destroy critical staging information for skin cancer. Every clinician performing minor surgery must master these skills and understand the clinical reasoning behind technique selection.


2. Anatomy Essentials

Skin Structure and Biopsy Depth

Understanding skin architecture is fundamental to technique selection:

LayerDepthStructuresBiopsy Relevance
Epidermis0.1-1.5mmKeratinocytes, melanocytes, Langerhans cellsShave biopsy captures this
Papillary Dermis0.3-0.5mmSuperficial vascular plexus, nerve endingsDeep shave reaches here
Reticular Dermis1-4mmCollagen bundles, deep vascular plexus, adnexaePunch biopsy required
Subcutaneous FatVariableAdipocytes, lobules, septa, vesselsDeep punch or incisional biopsy

Relaxed Skin Tension Lines (RSTLs / Langer's Lines)

The key to optimal scarring in excisional biopsies:

  • RSTLs run parallel to underlying muscle fibres and correspond to natural skin creases
  • On the face, they follow crow's feet, nasolabial folds, and forehead creases
  • Ellipse orientation: Always align the long axis of your ellipse ALONG the RSTLs
  • Result: Scars fall into natural creases and become significantly less visible [14]

Danger Zones (Anatomical Hazards)

Anatomical SiteStructure at RiskClinical ConsequencePrevention Strategy
TempleTemporal branch of Facial NerveBrow ptosis, forehead weaknessSuperficial dissection only
Cheek (middle third)Parotid Duct (Stensen's)Sialocele, fistulaRuns tragus to upper lip; stay superficial
Neck (posterior triangle)Spinal Accessory NerveShoulder weakness, scapular wingingVery superficial in posterior triangle
Hand (dorsum)Extensor tendonsTendon injury, functional impairmentTendons superficial; avoid deep dissection
Pretibial regionPoor vascularityDelayed healing, wound breakdownAvoid if possible; careful technique

Blood Supply Considerations

Regional blood supply affects healing and complication rates:

RegionVascularityHealingSpecial Considerations
Face/ScalpExcellentRapid (5-7 days)Bleeds well; heals well
Upper limbGoodModerate (10-14 days)Standard technique
TrunkModerateModerate (10-14 days)Tension from movement
Lower limbPoorSlow (14-21 days)High complication rate; avoid if possible
Pre-tibialVery poorVery slowHighest complication rate; consider alternatives

3. Local Anaesthesia

Pharmacology

AgentConcentrationOnsetDuration (Plain)Duration (+Adrenaline)Max Dose (Plain)Max Dose (+Adrenaline)
Lidocaine1-2%2-5 min30-60 min60-120 min3 mg/kg7 mg/kg
Bupivacaine0.25-0.5%5-15 min2-4 hours4-8 hours2 mg/kg3 mg/kg
Prilocaine1-2%5-10 min60-90 min2-4 hours6 mg/kg8 mg/kg
Topical (EMLA/LMX)Variable45-60 min1-2 hoursN/APer areaN/A

Maximum Volume Calculations

For lidocaine 1% with adrenaline (10 mg/mL):

  • 70 kg adult: Maximum 7 mg/kg = 490 mg = 49 mL of 1% lidocaine with adrenaline
  • 50 kg patient: Maximum 350 mg = 35 mL of 1% lidocaine with adrenaline

Practical tip: For minor skin biopsies, volumes of 1-5 mL are typical, well below toxic thresholds.

Adrenaline Safety Evidence

The traditional teaching to avoid adrenaline in digits has been definitively disproven:

StudySample SizeFindings
Lalonde et al. 2005 [8]3,110 casesZero digital necrosis with 1:100,000 adrenaline in fingers
Thomson et al. 2007 [9]1,111 casesNo ischaemic complications in digital blocks
Ilicki 2015 (Systematic Review) [10]> 10,000 casesNo reports of digital necrosis from adrenaline

Current evidence-based practice: Adrenaline 1:100,000 or 1:200,000 is safe in all anatomical locations including digits, ears, nose, and penis when used appropriately.

Benefits of Adrenaline in Local Anaesthesia

  1. Vasoconstriction: Provides bloodless operative field
  2. Delayed absorption: Prolongs anaesthetic duration
  3. Reduced systemic toxicity: Lower peak plasma levels
  4. Reduced total anaesthetic requirement: Better tissue penetration

Injection Technique

Pain reduction strategies (evidence-based):

TechniqueEvidence LevelMechanism
Slow injection (30 sec/mL)HighReduces tissue distension
Warming to body temperatureHighReduces cold-related pain
Buffering with sodium bicarbonateHighNeutralizes acidity (8.4% NaHCO3 1:10)
30G needleModerateSmaller puncture
Topical anaesthesia firstHighNumbs injection site

4. Indications for Biopsy Technique Selection

Technique Selection Algorithm

Clinical ScenarioRecommended TechniqueRationale
Inflammatory rash (psoriasis, eczema, lichen planus)Punch (4mm)Full dermis required for inflammatory pattern
Bullous disease (pemphigoid, pemphigus)Punch (4mm) x 2Perilesional biopsy for DIF studies + lesional for H&E
Suspected melanoma (dermoscopically atypical)Excision (2mm margin)Full depth mandatory for Breslow staging
Benign raised lesion (SK, viral wart, skin tag)ShaveQuick, minimal scarring, cosmetically acceptable
Nodular BCCDeep shave or punchEstablish diagnosis; definitive surgery follows
Suspected SCC (crusted, keratotic)Punch or deep shaveConfirm invasive vs. in-situ disease
Unknown rashPunch (4mm from edge)Include normal and abnormal tissue junction
Suspected vasculitisDeep punch (4mm+)Deep dermis/subcutis required for vessel wall assessment
PanniculitisIncisional biopsyIntact fat lobules required; punch inadequate
Large tumour for diagnosisIncisional biopsyRepresentative sample without complete excision
Alopecia (scarring vs. non-scarring)Punch (4mm) from active edgeRequires follicular architecture

Quality Markers for Skin Biopsy

MarkerStandardAudit Target
Correct technique selectionExcision for melanoma, punch for inflammatory100% compliance
Adequate specimen sizePunch ≥4mm for inflammatory dermatoses> 95%
No crush artefactToothed forceps, gentle handling> 95%
Complete clinical detailsSite, duration, description, differential on form100%
Correct transport mediumH&E = Formalin; DIF = Michel's/Zeus100%
Orientation suture (if needed)For excisions where margin mattersWhen indicated
Legible labellingPatient ID, site, date100%

5. Technique: Shave Biopsy

Definition and Mechanism

Shave biopsy removes a superficial portion of skin tangentially, including epidermis and variable amounts of dermis. The depth is controlled by blade angle and technique. [2,3]

Indications

AppropriateContraindicated
Seborrhoeic keratosisSuspected melanoma
Skin tags (acrochordons)Deep dermal pathology
Viral wartsSubcutaneous lesions
Benign intradermal naeviLesions requiring margin assessment
Superficial BCC (for diagnosis)Inflammatory dermatoses
Actinic keratosisBullous disease

Equipment Required

  • Antiseptic (chlorhexidine 0.5% in alcohol or povidone-iodine)
  • Lidocaine 1-2% with adrenaline 1:100,000
  • 2mL syringe, 25G (orange) needle
  • No. 15 scalpel blade OR DermaBlade
  • Toothed forceps (Adson or Gillies)
  • Haemostatic agent (aluminium chloride 20% / ferric subsulfate)
  • Specimen pot with 10% buffered formalin
  • Non-adherent dressing

Procedure: Step-by-Step

Step 1: Preparation and Consent

  • Explain procedure, expected outcome, scar appearance
  • Document consent including: bleeding, infection, incomplete excision, scar

Step 2: Anaesthesia

  • Clean site with antiseptic
  • Inject local anaesthetic beneath lesion, creating a raised bleb
  • Adrenaline-containing LA elevates lesion and provides haemostasis
  • Wait 2-5 minutes for full effect

Step 3: Technique

  • Hold blade parallel to skin surface (for superficial shave)
  • Angle blade 10-15° below horizontal for deeper sampling (saucerization)
  • Use gentle sawing motion to slice through base of lesion
  • Support lesion with forceps if needed (avoid crushing diagnostic tissue)
  • For saucerization: scoop downward to include mid-dermis

Step 4: Haemostasis

  • Apply aluminium chloride 20% (Monsel's solution) with cotton-tipped applicator
  • Alternative: light electrocautery or silver nitrate
  • Pressure for persistent oozing

Step 5: Specimen Handling

  • Place specimen in formalin immediately
  • Ensure adequate formalin volume (10:1 ratio formalin:tissue)
  • Label container clearly

Step 6: Dressing

  • Apply non-adherent dressing (Mepitel, Adaptic, or Allevyn)
  • Wound heals by secondary intention over 1-3 weeks

Saucerization (Deep Shave) Technique

For deeper sampling without ellipse:

  • Angle blade 30-45° and scoop to create dish-shaped excision
  • Allows sampling of mid-dermis
  • Useful for: suspected BCC, thick seborrhoeic keratoses, superficial SCC
  • Never for melanoma - still cannot assess true depth

Complications

ComplicationIncidencePreventionManagement
Bleeding5-10%Adrenaline LA, haemostatic agentsPressure, cautery
Infection1-3%Aseptic techniqueAntibiotics if cellulitis
Hypopigmented scarCommonPatient counsellingCosmetic camouflage
Recurrence5-15%Adequate depthRe-excision
Inadequate specimen2-5%Appropriate technique selectionRepeat biopsy

6. Technique: Punch Biopsy

Definition and Mechanism

Punch biopsy uses a circular cutting instrument to obtain a full-thickness cylindrical core of tissue including epidermis, dermis, and variable subcutaneous tissue. This is the gold standard for inflammatory dermatoses. [1,2,15]

Indications

Primary IndicationsRationale
Inflammatory skin diseaseFull dermis shows inflammatory pattern
Bullous diseasePerilesional specimen for DIF
Connective tissue diseaseDermal collagen changes
VasculitisDeep dermal vessels required
AlopeciaHair follicle architecture
Small pigmented lesions (if 2mm punch can excise completely)Full-thickness assessment
Unknown rashComprehensive histological evaluation

Punch Size Selection

SizeIndicationsClosure
2mmEyelid, small lesions, limited tissue areasOften no suture needed
3mmFace, standard rashMay heal without suture; 1 suture optional
4mmGold standard for inflammatory dermatoses1-2 sutures required
5mmWhen larger sample needed2 sutures
6mmPanniculitis, deep tissue sampling2+ sutures essential
8mmRarely used; incisional biopsy preferredMultiple sutures

Equipment Required

  • Antiseptic solution
  • Lidocaine 1-2% ± adrenaline
  • Disposable sterile punch (appropriate size)
  • Toothed forceps (fine-tipped)
  • Iris scissors (curved)
  • Suture material (non-absorbable 4-0 to 6-0 nylon or absorbable)
  • Specimen pot with 10% buffered formalin (or Michel's medium for DIF)
  • Needle holder
  • Dressing materials

Procedure: Step-by-Step

Step 1: Site Selection

  • Choose representative area of pathology
  • For inflammatory disease: include junction of normal and abnormal skin
  • For bullous disease: perilesional skin for DIF (uninvolved skin adjacent to blister)
  • Avoid areas of secondary change (excoriation, lichenification)

Step 2: Consent and Preparation

  • Explain procedure and expected scar (small circular/elliptical)
  • Document consent for bleeding, infection, scarring, need for repeat biopsy

Step 3: Anaesthesia

  • Clean with antiseptic
  • Inject LA beneath lesion to raise bleb
  • Avoid injecting into the lesion itself (distorts histology)
  • Wait for full anaesthetic effect

Step 4: Skin Stretching Technique (Critical)

  • Stretch skin perpendicular to RSTLs using non-dominant hand
  • This converts the circular defect into an elliptical wound when tension released
  • Elliptical wounds close with less tension and better cosmesis

Step 5: Punch Technique

  • Apply punch perpendicular to skin surface
  • Apply downward pressure with steady rotation in ONE direction
  • Twist like a corkscrew (not back-and-forth - this shreds collagen)
  • Continue until "give" is felt (entering subcutis)
  • Withdraw punch carefully

Step 6: Specimen Removal

  • Lift core gently with toothed forceps at deep edge (not crushing diagnostic tissue)
  • Snip base with iris scissors at level of subcutis
  • Handle specimen with minimal manipulation

Step 7: Haemostasis and Closure

  • Apply pressure or cautery for haemostasis
  • Close with simple interrupted suture (or allow secondary intention for ≤3mm)
  • Evert wound edges for optimal healing

Step 8: Specimen Handling

  • Place immediately in appropriate medium:
    • Formalin for routine H&E
    • Michel's medium for direct immunofluorescence
    • Fresh/saline for culture or special studies
  • Ensure proper labelling

Technical Pearls

One-Direction Twist: Twisting the punch back-and-forth shreds collagen fibres and creates crush artefact, potentially rendering histology uninterpretable. Always twist in one direction only.

Perilesional DIF: For bullous disease, the DIF specimen must come from perilesional UNINVOLVED skin (within 1cm of blister but not blistered). Blister fluid destroys antibodies.

The 10% Rule: Formalin volume should be at least 10x the tissue volume for adequate fixation.

Complications

ComplicationIncidencePreventionManagement
Bleeding3-8%Adrenaline, pressurePressure, cautery, suture
Infection1-2%Aseptic techniqueAntibiotics
Crush artefact5-10%Toothed forceps, gentle handlingRepeat biopsy
Scarring (hypertrophic/keloid)1-5% (site dependent)Avoid high-risk sitesSilicone, steroid injection
Inadequate depthless than 5%Appropriate punch sizeRepeat with larger punch

7. Technique: Incisional Biopsy

Definition and Indications

Incisional biopsy removes a representative portion of a larger lesion without attempting complete excision. It provides full-thickness tissue for diagnosis when complete excision is not practical or desirable initially. [3,16]

Indications

IndicationRationale
Large cutaneous tumoursConfirm diagnosis before definitive surgery
PanniculitisIntact fat lobules required (punch often inadequate)
Deep soft tissue massesFull-thickness sampling
Morphoea/sclerodermaDeep dermis and subcutis assessment
Large inflammatory lesionsRepresentative tissue from active edge
Lesions where complete excision would be morbidDiagnostic information guides treatment planning

Technique

Step 1: Planning

  • Mark ellipse at junction of abnormal and normal tissue (lesion edge)
  • For tumours: sample the most representative area (avoid necrotic centre)
  • For panniculitis: include subcutaneous fat in specimen

Step 2: Ellipse Design

  • Minimum 3:1 length-to-width ratio
  • Align long axis with RSTLs
  • Typically 1-2 cm length, 3-5 mm width

Step 3: Procedure

  • Anaesthetize with field block
  • Incise with No. 15 blade perpendicular to skin
  • Dissect ellipse to appropriate depth (often into subcutis)
  • Undermine if needed for closure

Step 4: Closure

  • Layered closure with deep absorbable sutures and superficial non-absorbable
  • Ensure eversion of wound edges

Panniculitis-Specific Considerations

  • Must include subcutaneous fat to depth of at least 1 cm
  • Standard punch biopsy is often inadequate
  • Incisional or deep excisional biopsy preferred
  • Specimen must be oriented and handled carefully to preserve fat lobule architecture

8. Technique: Excisional Biopsy

Definition and Indications

Excisional biopsy removes the entire lesion with a peripheral margin of clinically normal tissue. This is the gold standard for suspected melanoma and provides both diagnostic and therapeutic benefit. [4,5,6,17]

Mandatory Indications

IndicationMarginRationale
Suspected melanoma2mm clinicalBreslow depth determines WLE margin
Complete removal of benign lesions1-2mmTherapeutic and cosmetic
Lesions where margin status matters3-4mmBCC, SCC margins
Atypical naevi2mmComplete removal for diagnosis
Dermatofibrosarcoma protuberansWide marginsTumour margins critical

Margin Guidelines for Initial Excision

Lesion TypeRecommended Clinical Margin
Suspected melanoma (diagnostic)2mm
Confirmed melanoma (WLE) - Breslow ≤1mm1cm
Confirmed melanoma - Breslow 1-2mm1-2cm
Confirmed melanoma - Breslow > 2mm2cm
BCC (nodular)3-4mm
BCC (morphoeic/infiltrative)5mm+ or Mohs
SCC (well-differentiated)4-6mm
SCC (poorly differentiated)6mm+
Benign naevus1-2mm or intralesional

Ellipse Design Principles

The 3:1 Rule:

  • Length-to-width ratio of 3:1 prevents "dog ears"
  • On tight skin (scalp, shin), 4:1 ratio may be needed
  • Smaller ratios cause standing cones at ellipse ends

Orientation:

  • Align long axis with RSTLs (Langer's lines)
  • On face: follow wrinkle lines
  • Scar will contract along wound axis

Calculating Ellipse Dimensions:

  • If lesion is 6mm diameter with 2mm margins:
  • Width = 6mm + 2mm + 2mm = 10mm
  • Length = 10mm × 3 = 30mm (minimum)

Equipment Required

  • Sterile marking pen
  • Antiseptic solution
  • Lidocaine with adrenaline (field block)
  • No. 15 scalpel blade (or No. 10 for larger lesions)
  • Toothed forceps, scissors, needle holder
  • Suture material (deep absorbable + superficial non-absorbable)
  • Orientation suture (if required)
  • Formalin specimen container
  • Skin hooks (optional, for retraction)

Procedure: Step-by-Step

Step 1: Consent and Marking

  • Explain scar, infection, bleeding, possibility of wider excision if melanoma
  • Mark ellipse with sterile pen including margins
  • Photograph lesion if appropriate

Step 2: Anaesthesia

  • Perform field block around (not into) the ellipse
  • Wait for full effect (vasoconstrictive action of adrenaline)

Step 3: Incision

  • Hold scalpel perpendicular to skin surface
  • Cut along marked lines in single smooth strokes
  • Maintain consistent depth throughout
  • Blade angle prevents bevelling (which causes incomplete margins)

Step 4: Excision

  • Undermine specimen at level of subcutis
  • Use scissors or scalpel for dissection
  • Maintain even plane of dissection
  • Lift specimen with skin hook or forceps (at edge, not centre)

Step 5: Haemostasis

  • Achieve meticulous haemostasis with electrocautery or ties
  • Reduce haematoma risk (especially in anticoagulated patients)

Step 6: Specimen Orientation

  • Place orientation suture at 12 o'clock position
  • Mark on histology form: "Suture at 12 o'clock = superior"
  • Essential for margin assessment in melanoma and positive-margin re-excision

Step 7: Closure

LayerSuturePurpose
Deep dermis3-0 or 4-0 absorbable (Vicryl)Reduce tension, close dead space
Superficial4-0 to 6-0 non-absorbable (Nylon/Prolene)Skin edge approximation, eversion

Key Technical Points:

  • Close deep layer first to take tension off wound
  • Evert skin edges (slightly raised) - they will flatten
  • Avoid tight sutures (cause ischaemia and suture marks)
  • Space sutures 3-5mm apart

Step 8: Dressing

  • Apply Steri-strips perpendicular to incision
  • Cover with non-adherent dressing
  • Consider pressure dressing if bleeding risk

Dog Ear Correction

Cause: Ellipse too short (ratio less than 3:1) or tissue redundancy

Correction Technique:

  1. Identify standing cone at ellipse end
  2. Undermine around the cone
  3. Lay skin flat and mark excess as triangle (Burow's triangle)
  4. Excise triangle
  5. Close primarily

Prevention: Always design ellipse with adequate length-to-width ratio

Complications

ComplicationIncidencePreventionManagement
Wound infection2-5%Aseptic technique, prophylaxis for high-riskAntibiotics, drainage
Haematoma1-3%Meticulous haemostasis, pressure dressingEvacuate if large
Wound dehiscence1-2%Layered closure, reduce tensionSecondary intention or re-suture
Dog ears2-5%Adequate ellipse ratioSurgical revision
Hypertrophic scar2-10% (site dependent)Avoid tension, follow RSTLsSilicone, steroid injection
Incomplete excisionVariableAdequate margins, orientation markingRe-excision

9. Specimen Handling and Transport

Transport Media Selection

Transport MediumIndicationKey Points
10% Buffered FormalinRoutine histopathology (H&E)Standard for most specimens; 10:1 volume ratio
Michel's MediumDirect ImmunofluorescenceFor autoimmune bullous disease; preserves immunoglobulins
Zeus MediumExtended DIF transportAlternative to Michel's for longer transport times
Fresh/SalineTissue culture, geneticsShort transport time; coordinate with lab
Sterile ContainerMicrobiological cultureFor suspected infection

Critical Errors to Avoid

ErrorConsequencePrevention
DIF specimen in formalinDestroys antibodies; DIF failsSeparate pots; clear labelling
Inadequate formalin volumePoor fixation; autolysisMinimum 10:1 formalin:tissue ratio
Crush artefactUninterpretable histologyGentle handling; toothed forceps
Wrong patient labellingMisdiagnosisVerify at bedside; two identifiers
Delayed fixationAutolysisImmediate placement in fixative
Incomplete clinical informationPathologist cannot guide diagnosisFull clinical details on request form

Histology Request Form Requirements

Every request must include:

  1. Patient demographics: Full name, DOB, hospital number
  2. Specimen site: Precise anatomical location
  3. Clinical description: Size, colour, texture, duration
  4. Clinical history: Relevant medical history, medications
  5. Clinical differential diagnosis: Top 2-3 possibilities
  6. Specific questions: "Is this invasive?" "Are margins clear?"
  7. Special requests: Immunohistochemistry, DIF, special stains

Sample Documentation

Specimen: 4mm Punch Biopsy Right Upper Arm
Clinical Description: 2cm erythematous scaly plaque, 6-month history
Clinical History: 45F, no significant PMH, family history of psoriasis
Clinical Differential: 1. Psoriasis 2. Eczema 3. Mycosis fungoides
Questions for Pathologist: Inflammatory pattern? Evidence of lymphocyte atypia?

10. Anticoagulation Management

Evidence-Based Approach

Continuing anticoagulation for minor skin surgery is supported by systematic review evidence. The bleeding risk is manageable with appropriate technique, while stopping anticoagulation carries thromboembolic risks. [18,19]

Anticoagulant/Antiplatelet Management

AgentRecommendationEvidenceNotes
Aspirin (monotherapy)CONTINUELevel IStopping increases cardiovascular events
ClopidogrelCONTINUELevel ISame as aspirin for minor surgery
DAPT (Aspirin + Clopidogrel)CONTINUELevel IIPost-stent patients; never stop both
WarfarinCONTINUE if INR less than 3.5Level IICheck INR within 72h; delay if > 3.5
DOACs (Apixaban, Rivaroxaban)CONTINUE for punch/shaveLevel II-IIIConsider omitting morning dose for larger excisions
Bridging anticoagulationNOT requiredLevel IFor minor skin surgery with haemostatic technique

Haemostasis Strategies for Anticoagulated Patients

  1. Use adrenaline-containing local anaesthesia (vasoconstriction)
  2. Meticulous surgical haemostasis (electrocautery for all bleeding points)
  3. Pressure dressing post-procedure
  4. Absorbable deep sutures to obliterate dead space
  5. Elevate limb if lower extremity
  6. Avoid NSAIDs post-operatively
  7. Patient education: apply pressure if bleeding occurs

When to Refer for Specialist Input

  • INR > 4.0
  • Multiple anticoagulants/antiplatelets
  • Recent thromboembolic event (less than 3 months)
  • Mechanical heart valve
  • Large excision (> 2cm) on anticoagulation
  • High bleeding risk anatomical sites (scalp, face)

11. Special Situations

Bullous Disease Biopsy Protocol

For suspected autoimmune bullous disease (Bullous Pemphigoid, Pemphigus Vulgaris, Dermatitis Herpetiformis):

Two Biopsies Required:

BiopsySiteTransport MediumPurpose
Biopsy 1Lesional skin (blister edge)FormalinH&E histology - shows blister level
Biopsy 2Perilesional (non-blistered skin, within 1cm of blister)Michel's/ZeusDirect Immunofluorescence - shows antibody deposition

Critical Points:

  • DIF MUST be from uninvolved skin adjacent to blister
  • Blister fluid destroys immunoglobulins
  • Michel's medium (NOT formalin) for DIF specimen
  • Label pots clearly to avoid mix-up [11,12]

Vasculitis Biopsy

  • Requires deep tissue to visualize blood vessel walls
  • Use large punch (4-6mm) or small incisional biopsy
  • Sample fresh lesions (less than 48 hours old) - older lesions lose diagnostic features
  • Palpable purpura is the target lesion
  • Include subcutaneous fat if possible

Melanoma-in-Situ (Lentigo Maligna)

  • Edges often ill-defined on sun-damaged skin
  • Multiple "scouting punches" may be taken around clinical edge
  • Maps the true extent of disease before definitive staged excision
  • Staged excision (slow Mohs) or Wood's lamp assessment may be needed

Alopecia Biopsy

TypeBiopsy SiteSizeSpecial Requirements
Scarring alopeciaActive edge (erythematous border)4mm punch x2Horizontal and vertical sections
Non-scarring alopeciaArea of maximum activity4mm punch x2Include terminal and vellus hair

Technical tip: Two punches allow horizontal sectioning of one (for follicular count) and vertical sectioning of other (for inflammation pattern).

Paediatric Considerations

  • Topical anaesthesia (EMLA/LMX) applied 45-60 minutes prior
  • Consider intranasal midazolam or oral sedation for anxious children
  • Smaller punch sizes (2-3mm) often sufficient
  • Absorbable sutures preferred (avoid suture removal)
  • Careful site selection for cosmesis

12. Complications and Management

Intraoperative Complications

ComplicationRecognitionImmediate Management
Excessive bleedingObscured operative fieldPressure, identify source, electrocautery, ligature
Nerve injuryVisible nerve damage, motor weaknessAvoid further damage, consider repair, document, refer
Deep structure injuryVisualization of tendon, vesselStop, assess, specialist referral if needed
Inadequate anaesthesiaPatient painSupplement local anaesthesia

Post-operative Complications

ComplicationIncidencePreventionManagement
Wound infection2-5%Aseptic technique, dry woundOral antibiotics (flucloxacillin 500mg QDS); drain if abscess
Haematoma1-3%Haemostasis, pressure dressingSmall: observe; Large: evacuate
Dehiscence1-2%Tension-free closure, appropriate suturesSecondary intention or re-suture
Hypertrophic scar2-10%Follow RSTLs, reduce tensionSilicone gel, intralesional steroid
Keloid1-5% (predisposed individuals)Avoid biopsy in keloid-prone sitesIntralesional triamcinolone, silicone
Incomplete excisionVariableAdequate margins, specimen orientationRe-excision with appropriate margin
Suture reactionless than 5%Non-reactive suture materialsRemove sutures, antibiotics if infected
Contact dermatitisless than 5%Hypoallergenic dressingsRemove allergen, topical steroids

Wound Infection Risk Factors

Risk FactorRelative Risk
Lower extremity site2-3x
Diabetes mellitus2x
Immunosuppression3-5x
Contaminated wound5x
Poor nutritional status2x
Smoking2x

13. Post-Procedure Care

Patient Instructions

First 24-48 Hours:

  • Keep dressing clean and dry
  • Take paracetamol for discomfort (avoid NSAIDs - increase bleeding)
  • Elevate site if on limb
  • Avoid strenuous activity

After 48 Hours:

  • May shower gently; pat dry
  • Keep wound covered until sutures removed
  • Avoid swimming, baths, saunas until healed

Suture Removal Timing:

Anatomical SiteSuture RemovalFull Healing
Face5-7 days2-4 weeks
Scalp7-10 days4-6 weeks
Trunk/Upper limb10-14 days6-8 weeks
Lower limb/Foot14-21 days8-12 weeks

Warning Signs (Seek Medical Attention):

  • Increasing redness, warmth, or swelling around wound
  • Purulent discharge or pus
  • Fever
  • Bleeding that doesn't stop with 10 minutes of firm pressure
  • Wound opening (dehiscence)

Written Aftercare Information

Provide written instructions including:

  1. Wound care instructions
  2. Expected healing timeline
  3. Activity restrictions
  4. Warning signs
  5. Contact information for concerns
  6. Follow-up appointment details

14. Histology Interpretation

Understanding the Dermatopathology Report

TermMeaningClinical Significance
Breslow depth (mm)Vertical thickness from granular layer to deepest melanoma cellless than 1
mm: Good prognosis; > 4
mm: Poor prognosis; Determines WLE margin
Clark levelAnatomical depth (I-V: epidermis to subcutis)Largely replaced by Breslow; may be used when Breslow less than 1mm
Mitotic rateMitoses per mm²High rate indicates aggressive behaviour
UlcerationAbsence of epidermis over tumourUpstages melanoma; worse prognosis
RegressionHost immune response destroying tumourMay indicate true depth was greater
MicrosatellitesTumour deposits > 0.05mm from main tumourIndicates aggressive disease; upstages
Perineural invasionTumour around nervesRisk of recurrence; may need wider margin
Lymphovascular invasionTumour in vesselsRisk of metastasis

Common Histological Patterns

PatternCharacteristicAssociated Conditions
SpongioticIntercellular oedema in epidermisEczema, contact dermatitis
PsoriasiformRegular elongation of rete ridges, parakeratosisPsoriasis, pityriasis rubra pilaris
InterfaceBasal layer damage at dermal-epidermal junctionLichen planus, lupus, drug eruption
LichenoidBand-like lymphocytic infiltrate at DEJLichen planus, lichenoid drug eruption
VasculiticVessel wall inflammation, fibrinoid necrosisLeukocytoclastic vasculitis, HSP
GranulomatousGranuloma formation (epithelioid histiocytes)Sarcoidosis, granuloma annulare, TB
Subepidermal blisterBlister below epidermisBullous pemphigoid, epidermolysis bullosa
Intraepidermal blisterBlister within epidermisPemphigus vulgaris, pemphigus foliaceus

Direct Immunofluorescence Patterns

PatternAntibody LocationDiagnosis
Linear IgG/C3 at BMZBasement membrane zoneBullous pemphigoid
Chicken-wire IgGIntercellular spacesPemphigus vulgaris
Granular IgA at dermal papillaeTips of papillaeDermatitis herpetiformis
Linear IgA at BMZBasement membraneLinear IgA disease
Granular at BMZBasement membraneLupus band test positive

15. Common Pitfalls and Medicolegal Issues

Critical Errors

ErrorClinical ConsequenceMedicolegal RiskPrevention
Shaving a melanomaBreslow depth lost; staging impossibleHigh - delayed diagnosis, understagingExcise all suspicious pigmented lesions
Wrong transport mediumDIF fails; diagnosis delayedModerateClear labelling; two pots pre-prepared
Crush artefactHistology uninterpretableModerateGentle handling; proper forceps technique
Inadequate clinical historyPathologist unable to guide diagnosisModerateComplete request forms
Wrong site biopsyDiagnosis of wrong lesionHighMark before procedure; verify with patient
Failure to follow-up resultsDelayed diagnosis and treatmentVery highRobust recall system
Inadequate consentPatient unaware of implicationsModerateDocument discussion fully

Documentation Standards

Every procedure note should include:

  1. Indication: Why biopsy performed
  2. Consent: Documented discussion of risks and alternatives
  3. Site: Precise anatomical location
  4. Technique: Type of biopsy, punch size, or excision dimensions
  5. Anaesthetic: Type, volume, with/without adrenaline
  6. Findings: Macroscopic appearance of lesion
  7. Specimen: Where sent, which medium
  8. Closure: Suture type and number
  9. Complications: Any intraoperative issues
  10. Follow-up: Plan for review and results

Sample Procedure Note

PROCEDURE NOTE

Date: [Date]
Procedure: 4mm Punch Biopsy Left Shin
Indication: 6-month history of persistent scaly erythematous plaque, ? psoriasis vs. eczema
Consent: Verbal consent obtained. Risks (bleeding, infection, scar) discussed. Patient understands.
Anaesthetic: 1mL Lidocaine 2% with Adrenaline 1:100,000 infiltrated locally.
Procedure: Site prepped with chlorhexidine. 4mm punch biopsy performed using one-directional 
           technique. Core removed intact with toothed forceps at base (no crush). 
           Haemostasis achieved with pressure.
Closure: Single 4-0 Nylon simple interrupted suture.
Specimen: Sent in 10% buffered formalin to Dermatopathology.
Complications: None.
Post-op: Wound care advice given. Review with histology in 2 weeks. Suture removal in 14 days.

Signed: Dr [Name], [Date]

16. Examination Scenarios

Viva Scenario 1: Pigmented Lesion

Stem: 45-year-old woman with a 6mm irregularly pigmented lesion on her back. Dermoscopy shows irregular network and blue-white veil. What biopsy?

Model Answer:

"This lesion has dermoscopic features concerning for melanoma, specifically the irregular network and blue-white veil. The appropriate biopsy technique is complete excision with a 2mm clinical margin.

Shave biopsy is absolutely contraindicated as it would prevent accurate Breslow depth measurement, which is essential for staging and determining the subsequent wide local excision margin.

I would orient the specimen with a suture at 12 o'clock to allow the pathologist to identify margins for potential re-excision. If melanoma is confirmed, the Breslow depth will determine the WLE margin: 1cm for ≤1mm, 1-2cm for 1-2mm, and 2cm for > 2mm."

Viva Scenario 2: Inflammatory Rash

Stem: 70-year-old man with a persistent scaly red plaque on face, present for 2 years. Clinical differential is Bowen's disease vs. SCC vs. psoriasis. What biopsy?

Model Answer:

"For this well-defined plaque with differential diagnosis including neoplastic (Bowen's, SCC) and inflammatory (psoriasis) conditions, I would perform a 4mm punch biopsy.

This provides full-thickness tissue allowing assessment of:

  • Depth of invasion (if SCC)
  • Presence of in-situ vs. invasive disease
  • Inflammatory pattern (if psoriasis)

I would take the biopsy from the active edge of the lesion, avoiding any central ulceration. If histology confirms invasive SCC, definitive excision with 4-6mm margins would follow."

Viva Scenario 3: Bullous Disease

Stem: 65-year-old presents with tense blisters on limbs and trunk. You suspect Bullous Pemphigoid. How many biopsies and from where?

Model Answer:

"For suspected Bullous Pemphigoid, I would take two separate biopsies:

  1. Lesional biopsy: 4mm punch from the edge of a fresh blister, placed in formalin for H&E. This will show subepidermal blister with eosinophils.

  2. Perilesional biopsy: 4mm punch from uninvolved skin within 1cm of a blister (not blistered skin), placed in Michel's transport medium for Direct Immunofluorescence. This will show linear IgG and C3 at the basement membrane zone.

It is critical that the DIF specimen comes from perilesional non-blistered skin, as blister fluid destroys immunoglobulins. Formalin must NOT be used for DIF specimens."

Viva Scenario 4: Anticoagulated Patient

Stem: Patient on Warfarin (INR 2.8) needs a punch biopsy for a rash. What do you do?

Model Answer:

"I would proceed with the biopsy. An INR of 2.8 is within acceptable range (less than 3.5) for minor skin surgery.

My haemostatic strategy would include:

  • Using lidocaine with adrenaline for vasoconstriction
  • Electrocautery or aluminium chloride for haemostasis
  • Pressure dressing post-procedure
  • Suture closure rather than secondary intention

Current evidence supports continuing anticoagulation for minor skin procedures as the thromboembolic risk of stopping anticoagulation outweighs the manageable bleeding risk with appropriate technique."

Viva Scenario 5: Crush Artefact

Stem: FY2 doctor takes a punch biopsy but the pathology report says "Crush artefact. Uninterpretable."

Model Answer:

"Crush artefact occurs when the specimen is damaged during removal, typically by squeezing the diagnostic tissue with forceps.

The correct technique is:

  • Use toothed forceps (not smooth)
  • Grasp the specimen at the deep edge (subcutaneous fat), not the diagnostic dermis
  • Handle with minimal compression
  • Use one-directional twisting of the punch to avoid shredding collagen

The biopsy would need to be repeated using proper technique. This represents a preventable error that delays diagnosis and subjects the patient to an additional procedure."


17. Training Competency Framework

Expected Skill Progression

SkillMedical StudentFY1FY2ST3+ (Specialty)
Local anaesthesiaObservedSupervisedIndependentIndependent
Simple suturingAssistedSupervisedIndependentIndependent
Shave biopsyObservedSupervisedIndependentIndependent
Punch biopsyObservedObserved/AssistedSupervised/IndependentIndependent
Ellipse excisionObservedObservedAssisted/SupervisedIndependent
Complex excisionNot expectedNot expectedObservedSupervised/Independent

Assessment Criteria

Competence should be assessed against:

  1. Knowledge: Indications, contraindications, anatomy, complications
  2. Technical skill: Smooth technique, tissue handling, closure quality
  3. Decision-making: Appropriate technique selection for lesion type
  4. Communication: Consent, explanation, post-procedure instructions
  5. Documentation: Complete and accurate procedure notes
  6. Professionalism: Preparation, aseptic technique, equipment familiarity

18. Patient/Layperson Explanation

What is a Skin Biopsy?

A skin biopsy is a simple procedure where a small sample of your skin is taken and examined under a microscope. This helps doctors find out what is causing a rash, lump, or skin change.

Types of Skin Biopsy

  • Shave biopsy: A thin layer is shaved from the surface (like shaving off a raised mole)
  • Punch biopsy: A small circular sample is taken (like using a tiny cookie cutter)
  • Excision biopsy: The entire lump is removed with a small border of normal skin

Does it Hurt?

You will receive an injection of local anaesthetic (the same kind dentists use). The injection stings briefly, but after that the area is numb and you should feel no pain during the procedure.

Will it Leave a Scar?

There will be a small scar. The size depends on the type of biopsy. Most scars heal very well and fade significantly over several months. Your doctor will position the cut to minimize scarring.

How Long Does it Take?

The procedure takes about 5-15 minutes. You can go home immediately afterwards.

Aftercare

  • Keep the wound clean and dry for 48 hours
  • Take paracetamol if needed for discomfort
  • Follow the wound care instructions provided
  • Attend for suture removal if needed (usually 5-14 days depending on location)
  • Watch for signs of infection: increasing redness, swelling, pus, or fever

When Will I Get Results?

Usually 1-2 weeks. Your GP or specialist will contact you with the results and discuss any further treatment needed.


19. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationYearKey Recommendations
Skin Biopsy TechniquesBAD (British Association of Dermatologists)2021Best practice for technique selection, specimen handling
Melanoma ManagementNICE NG142015 (Updated 2022)2mm clinical margin for diagnostic excision; WLE margins by Breslow
Skin Cancer ManagementCancer Council Australia2020Excisional biopsy mandatory for suspected melanoma
NCCN Melanoma GuidelinesNCCN2024Narrow margin excision for diagnosis; appropriate margins for treatment
Perioperative AnticoagulationACCP2012Continue anticoagulation for minor dermatologic procedures

Evidence Summary

InterventionEvidence LevelKey Finding
Excision for suspected melanomaLevel IMandatory for accurate Breslow staging; shave biopsy contraindicated
Punch biopsy for inflammatory dermatosesLevel IIFull dermis required for histological pattern recognition
Adrenaline in digital blocksLevel ISafe; no digital necrosis in > 10,000 reported cases
Continuing anticoagulationLevel ISafe for minor skin surgery with appropriate haemostatic technique
Michel's medium for DIFLevel IISuperior preservation of immunoreactants vs. formalin
3:1 ellipse ratioLevel IIIPrevents dog-ear deformity

20. References

  1. Nischal U, Nischal Kc, Khopkar U. Techniques of skin biopsy and practical considerations. J Cutan Aesthet Surg. 2008;1(2):107-111. doi:10.4103/0974-2077.44174

  2. Alguire PC, Mathes BM. Skin biopsy techniques for the internist. J Gen Intern Med. 1998;13(1):46-54. doi:10.1046/j.1525-1497.1998.00009.x

  3. Pickett H. Shave and punch biopsy for skin lesions. Am Fam Physician. 2011;84(9):995-1002. PMID: 22046940

  4. Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol. 2010;146(3):234-239. doi:10.1001/archdermatol.2010.14

  5. Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208-250. doi:10.1016/j.jaad.2018.08.055

  6. Saco M, Thigpen J. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management. J Drugs Dermatol. 2014;13(5):531-536. PMID: 24809875

  7. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720. doi:10.1016/S1470-2045(08)70178-5

  8. Lalonde D, Bell M, Benoit P, Sparkes G, Denkler K, Chang P. A multicenter prospective study of 3,110 consecutive cases of elective epinephrine use in the fingers and hand: the Dalhousie Project clinical phase. J Hand Surg Am. 2005;30(5):1061-1067. doi:10.1016/j.jhsa.2005.05.006

  9. Thomson CJ, Lalonde DH, Denkler KA, Feicht AJ. A critical look at the evidence for and against elective epinephrine use in the finger. Plast Reconstr Surg. 2007;119(1):260-266. doi:10.1097/01.prs.0000237039.71227.11

  10. Ilicki J. Safety of epinephrine in digital nerve blocks: a literature review. J Emerg Med. 2015;49(5):799-809. doi:10.1016/j.jemermed.2015.06.025

  11. Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45(6):803-824. doi:10.1067/mjd.2001.117518

  12. Vodegel RM, Jonkman MF, Pas HH, de Jong MC. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol. 2004;151(1):112-118. doi:10.1111/j.1365-2133.2004.06006.x

  13. Linos E, Katz KA, Colditz GA. Skin cancer—the importance of prevention. JAMA Intern Med. 2016;176(10):1435-1436. doi:10.1001/jamainternmed.2016.5008

  14. Borges AF. Relaxed skin tension lines (RSTL) versus other skin lines. Plast Reconstr Surg. 1984;73(1):144-150. doi:10.1097/00006534-198401000-00036

  15. Elston DM, Stratman EJ, Miller SJ. Skin biopsy: Biopsy issues in specific diseases. J Am Acad Dermatol. 2016;74(1):1-16. doi:10.1016/j.jaad.2015.06.033

  16. Scolyer RA, Thompson JF, McCarthy SW, et al. Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. Australas J Dermatol. 2006;47(1):71-75. doi:10.1111/j.1440-0960.2006.00230.x

  17. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599-609. doi:10.1056/NEJMoa1310460

  18. Shimizu I, Jellinek NJ, Engel S, Engel ER. Anticoagulant and antiplatelet agent use in dermatologic surgery. Dermatol Surg. 2019;45(10):1226-1244. doi:10.1097/DSS.0000000000001837

  19. Lewis KG, Dufresne RG Jr. A meta-analysis of complications attributed to anticoagulation among patients following cutaneous surgery. Dermatol Surg. 2008;34(2):160-165. doi:10.1111/j.1524-4725.2007.34035.x

  20. Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol. 2011;65(3):576-583. doi:10.1016/j.jaad.2011.02.012


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. This does not replace supervised training for procedures.

Evidence trail

This article contains inline citation markers, but the full bibliography has not yet been imported as a visible references section. The page is still tracked through the editorial review pipeline below.

Tracked citations
Inline citations present
Reviewed by
MedVellum Editorial Team
Review date
17 Jan 2026

All clinical claims sourced from PubMed

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

  • Skin Anatomy
  • Local Anaesthesia Pharmacology

Differentials

Competing diagnoses and look-alikes to compare.

  • Melanoma Staging
  • Inflammatory Dermatoses

Consequences

Complications and downstream problems to keep in mind.

  • Wound Healing
  • Scar Management